Changes of T Lymphocyte Subsets in Peripheral Blood of Patients with Intermediate and Advanced Cervical Cancer before and after Nimotuzumab Combined with Chemoradiotherapy.

Teng, Fei; Cui, Guimin; Qian, Ligang; Zhao, Lujun

Teng, Fei; Cui, Guimin; Qian, Ligang; Zhao, Lujun.

Teng F; Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, China.
Cui G; Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, China.
Qian L; Department of Orthopedics, Affiliated Hospital of Hebei University, Baoding, China.
Zhao L; Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Int Arch Allergy Immunol ; 184(1): 85-97, 2023.

Article en En | MEDLINE | ID: mdl-36265457

Asunto(s)

Neoplasias del Cuello Uterino; Femenino; Humanos; Neoplasias del Cuello Uterino/tratamiento farmacológico; Antígeno Carcinoembrionario/uso terapéutico; Leptina; Quimioradioterapia/métodos; Células Th2; Subgrupos de Linfocitos T

Palabras clave

Chemoradiotherapy; Intermediate and advanced cervical cancer; Nimotuzumab; T lymphocyte subsets; Tumor markers

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google